2GRO image
Entry Detail
PDB ID:
2GRO
Keywords:
Title:
Crystal Structure of human RanGAP1-Ubc9-N85Q
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2006-04-24
Release Date:
2006-05-30
Method Details:
Experimental Method:
Resolution:
1.70 Å
R-Value Free:
0.20
R-Value Work:
0.18
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Ubiquitin-conjugating enzyme E2 I
Mutations:N85Q
Chain IDs:A
Chain Length:161
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Ran GTPase-activating protein 1
Chain IDs:B
Chain Length:170
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Lysine activation and functional analysis of E2-mediated conjugation in the SUMO pathway.
Nat.Struct.Mol.Biol. 13 491 499 (2006)
PMID: 16732283 DOI: 10.1038/nsmb1104

Abstact

E2 conjugating proteins that transfer ubiquitin and ubiquitin-like modifiers to substrate lysine residues must first activate the lysine nucleophile for conjugation. Genetic complementation revealed three side chains of the E2 Ubc9 that were crucial for normal growth. Kinetic analysis revealed modest binding defects but substantially lowered catalytic rates for these mutant alleles with respect to wild-type Ubc9. X-ray structures for wild-type and mutant human Ubc9-RanGAP1 complexes showed partial loss of contacts to the substrate lysine in mutant complexes. Computational analysis predicted pK perturbations for the substrate lysine, and Ubc9 mutations weakened pK suppression through improper side chain coordination. Biochemical studies with p53, RanGAP1 and the Nup358/RanBP2 E3 were used to determine rate constants and pK values, confirming both structural and computational predictions. It seems that Ubc9 uses an indirect mechanism to activate lysine for conjugation that may be conserved among E2 family members.

Legend

Protein

Chemical

Disease

Primary Citation of related structures